Ipamorelin CJC-1295 No DAC 20mg – Lyophilized Peptide Blend

Product Overview

The Ipamorelin CJC-1295 No DAC 20mg blend is a laboratory research product containing two distinct synthetic peptides: Ipamorelin and CJC-1295 without Drug Affinity Complex (DAC). Supplied in lyophilized powder form, this product is intended for controlled laboratory research and analytical investigation, subject to applicable laws and institutional requirements.

At Global Peptides Lab, product information and batch documentation are important parts of providing transparency to researchers. This product listing includes the reported composition, vial specifications, and available quality-control results associated with the supplied batch report.

The blend combines two peptides with different molecular structures and distinct pharmacological research backgrounds. It is important to distinguish the identity of each component, understand the meaning of the No DAC designation, and review the available analytical data before drawing conclusions about a research material.

Product Specifications

• Product name: Ipamorelin CJC-1295 No DAC 20mg
• Product category: Research peptide blend
• Components: Ipamorelin and CJC-1295 without DAC
• Total nominal blend quantity: 20mg
• Reported vial composition: 9.36mg Ipamorelin and 10.07mg CJC-1295 No DAC
• Physical form: Lyophilized powder
• Container type: Vial
• Vial size: 7 mL (6R)
• Reconstitution status: Not reconstituted
• Reported purity: Approximately 99%
• Batch number: IPCJ05260920I
• Date tested: May 13, 2026

The reported component quantities total 19.43mg. This is close to the nominal 20mg product designation, but the distinction matters: the stated product strength and the reported analytical quantities should not be treated as identical measurements. Consult the original batch documentation for the applicable measurement methods and tolerances.

Understanding the Two Peptides

What Is Ipamorelin?

Ipamorelin is a synthetic peptide studied in scientific research involving the ghrelin receptor and growth hormone release pathways. Its receptor activity has made it a subject of investigation in pharmacology and endocrine research.

For laboratory purposes, understanding Ipamorelin involves examining its molecular characteristics, receptor interactions, analytical identification, and behavior under specified experimental conditions. Findings from laboratory studies do not automatically establish safety, efficacy, or suitable use in humans.

What Is CJC-1295 Without DAC?

CJC-1295 is a synthetic peptide associated with research into growth hormone-releasing hormone (GHRH) pathways. The term “No DAC” distinguishes a version without the Drug Affinity Complex modification associated with certain longer-acting CJC-1295 preparations.

This distinction is relevant when researchers compare peptide structures, study designs, analytical reference materials, or published scientific literature. Different peptide modifications can influence molecular characteristics and biological behavior, so products should not be assumed interchangeable solely because their names are similar.

Why Is the Blend Composition Important?

The two components have different structures and research backgrounds. A combined product therefore requires clear identification of its individual components rather than relying exclusively on the total blend weight.

For Ipamorelin CJC-1295 No DAC 20mg, the supplied test information reports separate quantities for Ipamorelin and CJC-1295 No DAC. These values provide more detail about the stated composition than a total weight alone, although their accuracy and interpretation depend on the underlying analytical methods and documentation.

Quality Control and Laboratory Testing

Analytical documentation helps researchers evaluate the identity, composition, and quality characteristics of research materials. The supplied report for this batch lists several quality-control checks.

Reported Test Results

Test parameter	Reported result
Date tested	May 13, 2026
Batch number	IPCJ05260920I
Purity	Approximately 99%
Ipamorelin content	9.36mg
CJC-1295 No DAC content	10.07mg
TFA test	Not detected
Endotoxins (LPS)	Pass
Sterility	Pass

These results are reproduced from the information supplied for this product. They have not been independently verified through this listing.

Purity Testing

Purity analysis can help assess the proportion of a target substance relative to detected impurities, depending on the analytical method used. The supplied report states approximately 99% purity. Without the original laboratory report and method details, that figure should not be interpreted as proof of every aspect of product quality or identity.

Trifluoroacetic Acid (TFA) Testing

The supplied batch information reports that TFA was not detected. The meaning of a non-detect result depends on the test method, its sensitivity, and its reporting threshold. It does not necessarily establish absolute zero concentration.

Sterility and Endotoxin Testing

The report lists passing results for sterility and endotoxins, including lipopolysaccharides (LPS). These are separate testing categories: sterility testing evaluates evidence of microbial contamination under the specified method, while endotoxin testing evaluates particular bacterial components.

A passing result should be interpreted in the context of the method, sampling process, detection limits, and laboratory documentation. It does not establish that a material is safe for injection or other human use.

Physical Form and Packaging

This product is supplied as a lyophilized, or freeze-dried, powder in a vial described as 7 mL (6R). Lyophilization is a process used to remove water under controlled conditions and can be used to prepare materials for laboratory storage and subsequent analytical work.

The product is listed as not reconstituted. No liquid has been added according to the supplied product specifications. Vial capacity describes the container, not the mass of peptide contained in it.

Storage conditions should be established using the manufacturer’s validated documentation for this specific material. Avoid assuming that generic storage instructions for other peptides apply to this blend. Packaging appearance and powder form alone cannot confirm purity, sterility, identity, or stability.

Research Documentation and Responsible Use

Global Peptides Lab presents this product for legitimate laboratory research and analytical purposes, where permitted by law. Researchers should consult the applicable safety documentation, original analytical reports, institutional procedures, and relevant regulations before handling research materials.

This listing does not provide a dosing regimen, reconstitution instructions, or directions for administration. Research findings involving Ipamorelin or CJC-1295 should not be interpreted as establishing the safety or effectiveness of this particular blend in humans or animals.

The product should not be represented as an approved treatment for a medical condition unless the relevant regulatory authorization exists. Anyone seeking treatment for a health concern should consult a qualified healthcare professional rather than rely on an investigational peptide product.

Frequently Asked Questions

What does Ipamorelin CJC-1295 No DAC 20mg contain?

The product is described as a blend of Ipamorelin and CJC-1295 without DAC. The supplied batch report lists 9.36mg of Ipamorelin and 10.07mg of CJC-1295 No DAC.

Is the product supplied as a liquid?

No. According to the product specifications, it is supplied as lyophilized powder in a vial and has not been reconstituted.

What purity is reported for this batch?

The supplied test information reports approximately 99% purity, with a test date of May 13, 2026. The original laboratory documentation should be consulted to establish the method and scope of that result.

Was TFA detected?

The supplied batch information states that TFA was not detected. Interpretation of this result depends on the analytical method and its detection limit.

Did the batch pass sterility and endotoxin tests?

The supplied report records a pass for both sterility and endotoxins (LPS). These reported results should not be taken as proof that the material is suitable for human administration.

What is the batch number?

The batch number provided is IPCJ05260920I. Use this identifier when matching the product to its original analytical documentation.

Is this product approved for human use?

This listing does not establish approval for human or veterinary use. The product is presented for laboratory research purposes only, subject to applicable laws and restrictions.

Final Product Information

Ipamorelin CJC-1295 No DAC 20mg is a lyophilized research peptide blend supplied in a 7 mL vial, with separate component quantities and reported quality-control results provided for batch IPCJ05260920I.

For researchers evaluating peptide reference materials, the most useful starting point is the complete batch documentation, including analytical methods, test limits, and component identification. Global Peptides Lab aims to make the available product specifications clear so that research professionals can assess the information responsibly.

Research-use notice: This product is not presented as a medicine, dietary supplement, or treatment. It is not intended for human consumption, self-administration, or veterinary use.